ORALS

_______________

PRODUCT NAME FORM STRENGTH THERAPEUTIC AREA STATUS
APIXABANFilm-coated tablets2.5 and 5 mgAntithrombotic agentAvailable EU CTD
CLOPIDOGREL BESILATEFilm-coated Tablets75 mg/tab.Anti-thromboticAvailable EU CTD
DEXAMETHASONESoluble Tablets2 mg/tab.Glucocorticoid TherapyAvailable EU CTD
DEXAMETHASONESoluble Tablets4 mg/tabGlucocorticoid TherapyAvailable EU CTD
DEXAMETHASONESoluble Tablets8 mg/tabGlucocorticoid TherapyAvailable EU CTD
DEXAMETHASONESoluble Tablets10 mg/tabGlucocorticoid TherapyAvailable EU CTD
DEXAMETHASONESoluble Tablets20 mg/tabGlucocorticoid TherapyAvailable EU CTD
DUTASTERIDESoft Gel Capsules0.5 mg/capsBenign Prostatic HyperplasiaAvailable EU CTD
ELETRIPTANFilm-coated Tablets40 mg/tabMigraine TreatmentAvailable EU CTD
ELETRIPTANFilm-coated Tablets20 mg/tabMigraine TreatmentAvailable EU CTD
ELETRIPTANFilm-coated Tablets80 mg/tabMigraine TreatmentAvailable EU CTD
EZETIMIBETablets10 mg/tabPrimary HypercholesterolaemiaAvailable EU CTD
PARICALCITOLSoft Gel Capsules1 mcg/capSecondary HyperparathyroidismAvailable EU CTD
PARICALCITOLSoft Gel Capsules2 mcg/capSecondary HyperparathyroidismAvailable EU CTD
PARICALCITOLSoft Gel Capsules4 mcg/capSecondary HyperparathyroidismAvailable EU CTD
PARICALCITOLSol. Inj. 1ml vial or amp2 mcg/mlSecondary HyperparathyroidismAvailable EU CTD
PARICALCITOLSol. Inj. 1ml vial or amp5 mcg/mlSecondary HyperparathyroidismAvailable EU CTD
PARICALCITOLSol. Inj. 2ml vial or amp5 mcg/mlSecondary HyperparathyroidismAvailable EU CTD
ROSUVASTATIN CALCIUMFilm-coated Tablets5 mg/tabHypercholesterolaemia &Prevention of Cardiovascular EventsAvailable EU CTD
ROSUVASTATIN CALCIUMFilm-coated Tablets10 mg/tabHypercholesterolaemia &Prevention of Cardiovascular EventsAvailable EU CTD
ROSUVASTATIN CALCIUMFilm-coated Tablets20 mg/tabHypercholesterolaemia &Prevention of Cardiovascular EventsAvailable EU CTD
TICAGRELORFilm-coated tablets60 and 90 mgAntithrombotic agentAvailable EU CTD
ZOLEDRONIC ACIDConc. Sol. Inf. 5 ml vial4 mg/5 mlSkeletal Related Events in Advanced Malignancies & Tumour-Induced ypercalcaemiaAvailable EU CTD

OPTHALMICS

 

 

INJECTABLES

 

 

ORALS

 

 

OTHERS